Evidence map›Paper›PMID 40999021›Full record

ArticleScientific reports2025

A novel method to assess motor planning deficits in patients with parkinson's disease and mild cognitive impairment.

Natalie J Maffitt, Sattwika Banerjee, Subhajit Sarkar, Suchismita Majumdar, Supriyo Choudhury, Hrishikesh Kumar, Demetris S Soteropoulos, Alexander Kraskov

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Natalie J MaffittBiosciences Institute, Newcastle University, Newcastle Upon Tyne, UK.
Sattwika BanerjeeInstitute of Neurosciences Kolkata, Kolkata, India.
Subhajit SarkarInstitute of Neurosciences Kolkata, Kolkata, India.
Suchismita MajumdarInstitute of Neurosciences Kolkata, Kolkata, India.
Supriyo ChoudhuryInstitute of Neurosciences Kolkata, Kolkata, India.
Hrishikesh KumarInstitute of Neurosciences Kolkata, Kolkata, India.
Demetris S SoteropoulosBiosciences Institute, Newcastle University, Newcastle Upon Tyne, UK.
Alexander KraskovBiosciences Institute, Newcastle University, Newcastle Upon Tyne, UK. sasha.kraskov@newcastle.ac.uk.

Funding

Biotechnology and Biological Sciences Research Council BB/P006027/1
6 · The paper itself

Abstract

It is well established that patients with Parkinson's disease (PD) show deficits with movement execution, however experiences of motor planning dysfunction, and how they relate to the severity of motor symptoms, remains unclear. To investigate motor planning in PD, we designed a novel precision-grip task. PD patients showed significantly higher uncertainty in task performance compared to healthy controls, indicative of motor planning deficits. Performance of PD patients did not correlate with indicators of disease severity or subtype, yet patients on a higher daily levodopa dosage showed reduced motor planning deficits. Interestingly, these deficits were present even in recently diagnosed patients, implying that this measure may have potential as an early marker of motor planning impairment. These results suggest that the motor planning deficits revealed by our task may arise from separate pathological processes to that of motor execution dysfunction in PD, though might be alleviated with higher treatment dosages.

Indexed as

Cognitive DysfunctionParkinson DiseaseAgedCase-Control StudiesFemaleHand StrengthHumansLevodopaMaleMiddle AgedPsychomotor PerformanceLevodopaAmbiguityDopamine.GraspingMild cognitive impairmentMotor planningParkinson’s disease

Identifiers

PMID40999021
PMCPMC12464217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.